Tan Kevin

CIK 00018840562 companiesCHARLESTOWN, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001884056

Recent Transactions

34 trades

Sale
Solid Biosciences Inc.$SLDB
Common Stock
2026-02-18$5.82/sh−5,404→ 99,422 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Common Stock
2026-02-13+10,625→ 104,826 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Restricted Stock Units
2026-02-13−10,625→ 21,250 total
Sale
Solid Biosciences Inc.$SLDB
Common Stock
2026-02-04$6.44/sh−14,783→ 94,201 total
Sale
Solid Biosciences Inc.$SLDB
Common Stock
2026-02-02$6.44/sh−26,837→ 108,984 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Common Stock
2026-01-31+33,075→ 135,821 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Restricted Stock Units
2026-01-31−33,075→ 99,225 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Common Stock
2026-01-29+56,646→ 102,746 total
Award
Solid Biosciences Inc.$SLDB
Restricted Stock Units
2026-01-29+93,500→ 93,500 total
Award
Solid Biosciences Inc.$SLDB
Employee Stock Option (Right to Buy)
2026-01-29+187,000→ 187,000 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Performance Stock Units
2026-01-29−56,646→ 0 total
Sale
Solid Biosciences Inc.$SLDB
Common Stock
2026-01-13$5.27/sh−5,704→ 46,100 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Common Stock
2026-01-09+11,250→ 51,804 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Restricted Stock Units
2026-01-09−11,250→ 11,250 total
Award
Solid Biosciences Inc.$SLDB
Restricted Stock Units
2025-08-14+62,500→ 62,500 total
Award
Solid Biosciences Inc.$SLDB
Employee Stock Option (Right to Buy)
2025-08-14+125,000→ 125,000 total
Sale
Solid Biosciences Inc.$SLDB
Common Stock
2025-02-14$3.96/sh−3,164→ 32,250 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Common Stock
2025-02-13+10,625→ 35,414 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Restricted Stock Units
2025-02-13−10,625→ 31,875 total
Award
Solid Biosciences Inc.$SLDB
Restricted Stock Units
2025-01-31+132,300→ 132,300 total
Sale
Solid Biosciences Inc.$SLDB
Common Stock
2025-01-10$3.89/sh−4,073→ 24,789 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Restricted Stock Units
2025-01-09−11,250→ 22,500 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Common Stock
2025-01-09+11,250→ 28,862 total
Award
Solid Biosciences Inc.$SLDB
Employee Stock Option (Right to Buy)
2024-02-13+85,000→ 85,000 total
Award
Solid Biosciences Inc.$SLDB
Restricted Stock Units
2024-02-13+42,500→ 42,500 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Common Stock
2024-01-09+11,250→ 13,243 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Restricted Stock Units
2024-01-09−11,250→ 33,750 total
Sale
Solid Biosciences Inc.$SLDB
Common Stock
2024-01-09$8.20/sh−3,935→ 9,308 total
Award
Solid Biosciences Inc.$SLDB
Restricted Stock Units
2023-01-09+45,000→ 45,000 total
Award
Solid Biosciences Inc.$SLDB
Employee Stock Option (Right to Buy)
2023-01-09+90,000→ 90,000 total
Award
Cartesian Therapeutics, Inc.$RNAC
Employee Stock Option (right to buy)
2022-01-03+340,000→ 340,000 total
Award
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2022-01-03+72,000→ 77,000 total
Purchase
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2021-12-02$3.03/sh+5,000→ 5,000 total
Award
Cartesian Therapeutics, Inc.$RNAC
Employee Stock Option (right to buy)
2021-09-20+750,000→ 750,000 total

Companies

Recent Filings

Address

C/O SOLID BIOSCIENCES INC. 500 RUTHERFORD AVENUE, THIRD FLOOR

CHARLESTOWN, MA, 02129

View on SEC.gov